The COVID-19 pandemic is changing a lot right now. Here are three changes to which I’m paying close attention How we talk about healthcare reform How we talk about rationing ethically How the virus is spreading silently Coronavirus & Healthcare Reform Christopher Beem writes in The Conversation that the coronavirus pandemic will push Americans to … Continue reading Coronavirus: It’s Changing Our Conversation About Healthcare Reform, Ethics & Silent Spread
Can Liberals, Conservatives and Libertarians find common ground on an approach to reforming healthcare? - If you are Libertarian, click here. - If you are Liberal, click here. - If you are Conservative, click here. Jump to Summary Conclusion For Libertarians For Libertarians For Libertarians Americans are divided politically, now perhaps more so than at … Continue reading How Could Oregon-style Healthcare Reform Satisfy Liberals, Conservatives and Libertarians?
Fixing US Healthcare blog has touted the Oregon Health Plan of 1994 as a model of U.S. healthcare reform. But what are the strongest criticisms of OHP? Let’s look at 8 criticisms from 3 critics. Which criticisms are valid and which ones questionable? Finally, what about ethics? Jonathan Oberlander PhD: 5 Criticisms The first critic … Continue reading FAQ: What Are the Strongest Criticisms of the Oregon Health Plan for Healthcare Reform?
The Trump-GOP tax plan will add to the national debt by $1 trillion (Joint Committee on Taxation) or $1.4 trillion (Congressional Budget Office). Under the pay-as-you-go (PAYGO) law, Congress will need to make a choice to cut Medicare or to allow the increase of the national debt. The PAYGO law says that the revenue shortfall … Continue reading Will New Trump-GOP Tax Plan Trigger PAYGO Cuts to Medicare?
Executive Summary Some experts say that cost-benefit analysis is the way to restrain soaring healthcare costs and reform the system. How exactly would cost-benefit analysis work? This blog argues: Forget the caviar. But keep costworthy care on the menu. To explain what this means, let’s look at the case of Repatha (evolocumab), the new cholesterol-lowering drug, … Continue reading FAQ: How Would Cost-Benefit Analysis Be Used to Restrain Healthcare Costs? – The Case of an Expensive New Cholesterol Drug